| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/16/2003 | CA2453173A1 Mycobacterial antigens expressed during latency |
| 01/16/2003 | CA2453100A1 Novel human hepatoma lines, methods for obtaining same and uses thereof |
| 01/16/2003 | CA2453098A1 Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| 01/16/2003 | CA2453075A1 Drug metabolizing enzymes |
| 01/16/2003 | CA2453062A1 Group b streptococcus bvh-a5 antigens and corresponding dna fragments |
| 01/16/2003 | CA2452835A1 Aromatic sulfenates for type i phototherapy |
| 01/16/2003 | CA2452695A1 Novel surface exposed immunoglobulin d-binding protein from moraxella catarrhalis |
| 01/16/2003 | CA2452651A1 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences |
| 01/16/2003 | CA2452628A1 Methylation of histone h4 at arginine 3 |
| 01/16/2003 | CA2452501A1 Secreted proteins |
| 01/16/2003 | CA2452366A1 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis |
| 01/16/2003 | CA2452315A1 Expression of functional human olfactory cyclic nucleotide gated (cng) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 01/16/2003 | CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 01/16/2003 | CA2452119A1 Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof |
| 01/16/2003 | CA2451741A1 Peyers's patch and/or m-celle targeting ligands |
| 01/16/2003 | CA2451395A1 Novel pgc-1 isoforms and uses therefor |
| 01/16/2003 | CA2451087A1 Use of histamine receptor h3 gene in controlling body weight or food intake |
| 01/16/2003 | CA2450502A1 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | CA2450236A1 Phage displayed pdz domain ligands |
| 01/16/2003 | CA2450020A1 Dna sequences comprising gene transcription regulatory qualities and methods for detecting and using dna sequences |
| 01/16/2003 | CA2449875A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/16/2003 | CA2443644A1 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 01/16/2003 | CA2442741A1 Human secreted proteins |
| 01/16/2003 | CA2441416A1 Human secreted proteins |
| 01/15/2003 | EP1275726A2 A method for producing influenza hemagglutinin multivalent vaccines |
| 01/15/2003 | EP1275725A1 Use of the nucleotide sequence of the lactobacillus casei lactose operon promoter for regulating gene expression by means of an antiterminator protein |
| 01/15/2003 | EP1275719A1 Gene concerning brassinosteroid-sensitivity of plants and utilization thereof |
| 01/15/2003 | EP1275718A2 TCF mutant |
| 01/15/2003 | EP1275717A1 Proliferative glomerular nephritis-associated gene |
| 01/15/2003 | EP1275716A2 Modified DNA molecule, recombinant containing the same thing, and uses thereof |
| 01/15/2003 | EP1275659A1 Novel physiologically active peptides and use thereof |
| 01/15/2003 | EP1275658A1 Compositions comprising a parvovirus VP1-variant and a parvovirus NS1 protein for induction of cytolysis |
| 01/15/2003 | EP1275437A2 Use of an adsorbent for interleukins, process for removing the same |
| 01/15/2003 | EP1275006A2 Proteomic analysis using activity-based probe libraries |
| 01/15/2003 | EP1275000A1 Detection of erythropoietin and erythtropoietin receptor |
| 01/15/2003 | EP1274866A2 Diagnosis of diseases associated with metastasis |
| 01/15/2003 | EP1274865A2 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis |
| 01/15/2003 | EP1274859A1 Specific peptide substrate for human yak1, yak3a, and yak3b and yeast yak1 protein kinases |
| 01/15/2003 | EP1274857A1 Inhibitor of differentiation knockout mammals and methods of use thereof |
| 01/15/2003 | EP1274852A2 Targeted vaccine delivery systems |
| 01/15/2003 | EP1274851A1 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide |
| 01/15/2003 | EP1274848A2 Mre11 orthologue and uses thereof |
| 01/15/2003 | EP1274846A2 Plastid transformation vectors for expressing human proteins in plants |
| 01/15/2003 | EP1274845A2 Lipid binding protein 3 |
| 01/15/2003 | EP1274844A2 G-protein coupled receptors and nucleic acids encoding same |
| 01/15/2003 | EP1274843A1 New lipid binding protein 2 |
| 01/15/2003 | EP1274842A2 Lipid binding protein 4 |
| 01/15/2003 | EP1274841A2 Regulation of human cyslt2-like gpcr protein |
| 01/15/2003 | EP1274840A2 Ligand for herpes simplex virus entry mediator and methods of use |
| 01/15/2003 | EP1274839A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 01/15/2003 | EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2003 | EP1274831A2 Polynucleotides encoding novel secreted proteins |
| 01/15/2003 | EP1274731A1 Human hepatocyte growth factor activator inhibitor homologue |
| 01/15/2003 | EP1274730A2 Integrin/adhesion antagonists |
| 01/15/2003 | EP1274729A2 G protein coupled receptor |
| 01/15/2003 | EP1274728A2 Methods and compositions for the prevention and treatment of anemia |
| 01/15/2003 | EP1274727A1 Nk-2 homeobox transcription factor |
| 01/15/2003 | EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 01/15/2003 | EP1274725A2 Neutralizing immunogenic hev polypeptides |
| 01/15/2003 | EP1274723A2 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 01/15/2003 | EP1274721A1 Haemostatically active preparation containing vwf and method for the production thereof |
| 01/15/2003 | EP1274720A1 Albumin fusion proteins |
| 01/15/2003 | EP1274719A2 Albumin fusion proteins |
| 01/15/2003 | EP1274716A1 Novel nucleic acids and polypeptides |
| 01/15/2003 | EP1274715A2 Polynucleotides encoding novel secreted proteins |
| 01/15/2003 | EP1274714A2 Polynucleotides encoding novel secreted proteins |
| 01/15/2003 | EP1274463A2 Metastasis genes and uses thereof |
| 01/15/2003 | EP1274453A2 Recombinant intracellular pathogen vaccines and methods for use |
| 01/15/2003 | EP1274451A1 Sperm factor oscillogenin |
| 01/15/2003 | EP1274450A2 Cytokine uses; compositions; methods |
| 01/15/2003 | EP1274442A1 Method for modulating tumor growth and metastasis of tumor cells |
| 01/15/2003 | EP1274307A2 Hr-elicitors to inhibit postharvest disease or desiccation of fruits or vegetables |
| 01/15/2003 | EP1274305A2 Aids ancestral viruses and vaccines |
| 01/15/2003 | EP1235488A4 Product and method for control of obesity |
| 01/15/2003 | EP1157105A4 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
| 01/15/2003 | EP1121016B1 Method for preserving a hemoglobin blood substitute |
| 01/15/2003 | EP1071765A4 Alk-1 responds to tgf-beta and signals through smad-1 and smad-5 |
| 01/15/2003 | EP1015627A4 Method for detecting a target compound using a nucleic acid ligand |
| 01/15/2003 | EP0979235A4 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof |
| 01/15/2003 | EP0958376A4 Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 01/15/2003 | EP0853450A4 Treatment of vascular injury |
| 01/15/2003 | EP0833659A4 Therapeutic fragments of von willebrand factor |
| 01/15/2003 | EP0815235B1 Vaccines for plague |
| 01/15/2003 | CN1391612A Thermophilic amino acid biosynthesis system enzyme gene of thermotolerant coryneform bacterium |
| 01/15/2003 | CN1391610A BASB118 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/15/2003 | CN1391608A Cloning, expression and characterisation of gene expressed in tumour cells and involved in regulation of immune response |
| 01/15/2003 | CN1391581A Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 01/15/2003 | CN1391580A Peptides |
| 01/15/2003 | CN1391579A HEV antigenic peptide and its method |
| 01/15/2003 | CN1391481A 疫苗 Vaccine |
| 01/15/2003 | CN1390936A Human atrial natriuretic peptide gene, its strong mutant and its application in treating relative diseases |
| 01/15/2003 | CN1390935A Human hematolysis associated membrane protein and its coding sequence, preparing process and usage |
| 01/15/2003 | CN1390854A Process for rourifying insuline |
| 01/15/2003 | CN1390853A Process for preparing thymic peptide |
| 01/15/2003 | CN1390852A Human auricular fibrillation pathogene and coding protein and its usage |
| 01/15/2003 | CN1390851A Bombesin of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390850A Neurotrophic factor of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390849A Neurotrophic peptide of Bombina maxima and its preparing process and genes |
| 01/15/2003 | CN1390847A Salmon's calcitonin gene synthesized by plant preference codon and its application |
| 01/15/2003 | CN1390468A Manufacture of transparent protein |